Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRX-I vs linezolid for complicated skin and soft tissue infections
CTR20140056Phase 2Completed
- Sponsor
- Resolian
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of contezolid in skin and soft tissue infections (SSTIs), sponsored by Resolian. Started Mar 2014; status: completed.
02
Drugs
contezolid
03
Conditions
skin and soft tissue infections (SSTIs)
Beyond the preview
Go deeper on CTR20140056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140056.